Robert Walker, MD discussed the company's application for full licensure and the importance of vaccination.
Robert Walker, MD
Advertisement
Chief Medical Officer at Novavax.
Articles by Robert Walker, MD
The latest Phase 2/3 trial results show NVX-CoV2601 outperforms its predecessor, offering protection against emerging COVID-19 strains.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Phase 3 Trial Confirms Superior Efficacy of Oral Pritelivir for Refractory HSV in Immunocompromised Patients
2
Developing the Next Generation of Rifamycins for Non-TB Mycobacteria in a Postantibiotic Era
3
Higher Acceptability of 1 Injectable in First Head-to-Head Comparison of Long-Acting PrEP
4
